Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer. / Frederiksen, C. ; Qvortrup, C.; Christensen, I.J. ; Glimelius, B. ; Berglund, Å.; Jensen, B.V.; Nielsen, S.E.; Keldsen, N.; Nielsen, H.J.; Brunner, Nils; Pfeiffer, P. .

In: Annals of Oncology, Vol. 22, No. 2, 2011, p. 369-375.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Frederiksen, C, Qvortrup, C, Christensen, IJ, Glimelius, B, Berglund, Å, Jensen, BV, Nielsen, SE, Keldsen, N, Nielsen, HJ, Brunner, N & Pfeiffer, P 2011, 'Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer', Annals of Oncology, vol. 22, no. 2, pp. 369-375. https://doi.org/10.1093/annonc/mdq354

APA

Frederiksen, C., Qvortrup, C., Christensen, I. J., Glimelius, B., Berglund, Å., Jensen, B. V., ... Pfeiffer, P. (2011). Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer. Annals of Oncology, 22(2), 369-375. https://doi.org/10.1093/annonc/mdq354

Vancouver

Frederiksen C, Qvortrup C, Christensen IJ, Glimelius B, Berglund Å, Jensen BV et al. Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer. Annals of Oncology. 2011;22(2):369-375. https://doi.org/10.1093/annonc/mdq354

Author

Frederiksen, C. ; Qvortrup, C. ; Christensen, I.J. ; Glimelius, B. ; Berglund, Å. ; Jensen, B.V. ; Nielsen, S.E. ; Keldsen, N. ; Nielsen, H.J. ; Brunner, Nils ; Pfeiffer, P. . / Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer. In: Annals of Oncology. 2011 ; Vol. 22, No. 2. pp. 369-375.

Bibtex

@article{d43dd71b895e4ff0a0ec9f68594194d3,
title = "Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer",
keywords = "LIFE, Biomarkers, metastatic colorectal cancer, overall survival, progression-free survival, response, XELOX",
author = "C. Frederiksen and C. Qvortrup and I.J. Christensen and B. Glimelius and {\AA}. Berglund and B.V. Jensen and S.E. Nielsen and N. Keldsen and H.J. Nielsen and Nils Brunner and P. Pfeiffer",
year = "2011",
doi = "10.1093/annonc/mdq354",
language = "English",
volume = "22",
pages = "369--375",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "2",

}

RIS

TY - JOUR

T1 - Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer

AU - Frederiksen, C.

AU - Qvortrup, C.

AU - Christensen, I.J.

AU - Glimelius, B.

AU - Berglund, Å.

AU - Jensen, B.V.

AU - Nielsen, S.E.

AU - Keldsen, N.

AU - Nielsen, H.J.

AU - Brunner, Nils

AU - Pfeiffer, P.

PY - 2011

Y1 - 2011

KW - LIFE

KW - Biomarkers

KW - metastatic colorectal cancer

KW - overall survival

KW - progression-free survival

KW - response

KW - XELOX

U2 - 10.1093/annonc/mdq354

DO - 10.1093/annonc/mdq354

M3 - Journal article

VL - 22

SP - 369

EP - 375

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 2

ER -

ID: 32147175